廣發證券:予中手遊(0302.HK)“買入”評級 目標價5.79港元
廣發證券發表研究報告指,中手遊(0302.HK)知識產權(IP)賦能遊戲效果突出,當中“授權+收購”的儲備版權超過一百款,加上公司發行能力突出,給予其“買入”評級,目標價5.79港元。
該行指,公司代理遊戲《新射鵰羣俠傳》上線後穩居暢銷榜前列,表現超預期;而自研產品《龍城傳奇》的前期測試數據良好,即將進行買量投放;與騰訊(0700.HK)及字節跳動合作的多款重磅產品將在第四季上線,業績有望加速增長。
該行預計,公司2020-22年非處用會計準則純利分別為7.94億、11.4億及14.1億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.